We are live on ! Find out more
ORIAU

Orion Biotech Opportunities Corp. Units

Delisted

ORIAU was delisted on the 25th of April, 2023.

11 hedge funds and large institutions have $25.1M invested in Orion Biotech Opportunities Corp. Units in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

21% less funds holding

Funds holding: 1411 (-3)

24% less capital invested

Capital invested by funds: $33.2M → $25.1M (-$8.02M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ORIAU Hedge Fund Activity: Q2 2022 in Review

11 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q2 2022, worth a combined $25.1M — down 24% from $33.2M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ORIAU and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.

The largest seller was First Trust Capital Management, exiting entirely with an estimated $1.71M sold.

  • 11 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q2 2022, down from 14 in Q1 2022.
  • Funds reported $25.1M of Orion Biotech Opportunities Corp. Units stock for Q2 2022, down 24% quarter-over-quarter.
  • 0 funds opened new Orion Biotech Opportunities Corp. Units positions in Q2 2022 and 3 closed out, a net change of -3 holders.
  • The largest Orion Biotech Opportunities Corp. Units seller in Q2 2022 was First Trust Capital Management, an estimated $1.71M sold.

Based on aggregated 13F filings for Q2 2022.